Your Position: Home > Journal List > China Medicine > Paper

Effects of triptolide on patients with diabetic nephropathy of Ⅲ stage

( views:413, downloads:0 )
Author:
TONG Yong(Department of Chinese Medicine,Second Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,China)
JI Ling-qin(Department of Chinese Medicine,Second Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,China)
LI Yan-ying()
YAO Qiong()
YANG Xi-qiang()
CAO A-dan()
Journal Title:
China Medicine
Issue:
Volume 07, Issue 11, 2012
DOI:
10.3760/cma.j.issn.1673-4777.2012.11.032
Key Word:
Diabetic nephropathies;Oxidative stress;Triptolide

Abstract: Objective To investigate the effects of triptolide on diabetic nephropathy (DN).Methods Seventy-five patients of type 2 diabetes with DN of Ⅲ stage were randomized into two groups.Fourty patients in treatment group received triptolide 60 mg/d and losartan 100 mg/d,while the other 35 patients in control group received losartan 100 mg/d; with a course of 12 weeks in each group.The levels of 24 h urine albumin,laminin (LN),ⅣV-collagen(C-Ⅳ),high sensitive C-creative protein (hsCRP) and urinary podocytes were measured before and after the treatments.Results After 12 weeks of treatment,the levels of 24h urine albumin,LN,C-Ⅳ,hsCRP,and urinary podocytes in two groups decreased significantly (P < 0.05) ; the level of LN and hsCRP in treatment group decreased more than that in control group(P >0.05) ; the level of 24 h urine albumin,C-Ⅳ and urinary podocytes in treatment group decreased more significantly than that in control group (P < 0.05).No serious adverse reactions occurred in both groups.Conclusions Triptolide may decrease the amount of proteinuria of diabetic nephropathy and in DN developing.The mechanism appears to be related with suppressing expressions of inflammatory cytokines.

  • [1]岳欣阁,秦贵军,张颖辉,等.吡咯烷二硫代氨基甲酸酯联合霉酚酸酯保护糖尿病大鼠肾脏机制的实验研究.中华内分泌代谢,2008,24(2):196-199.
  • [2]李法鹏,王银鼎,樊华.雷公藤多甙对糖尿病肾病Ⅳ期患者尿蛋白的影响.临床内科杂志,2010,27(3):194-195.
  • [3]谢彤,钟应雄,麦伟民,等.雷公藤多苷治疗IgA肾病的临床研究.中国医师进修杂志,2008,31(1):35-36.
  • [4]冯继明,余燕敏,安增梅,等.雷公藤多甙对成人隐匿性自身免疫性糖尿病患者谷氨酸脱羧酶抗体和B细胞功能的影响.中国医药,2006,1(8):468-470.
  • [5]温取.雷公藤多甙和米非司酮治疗子宫肌瘤疗效观察.中国综合临床,2005,21 (3):277-279.
  • [6]吴爱红.雷公藤多苷联合低分子肝素治疗慢性肾小球肾炎51例分析.中国基层医药,2011,18(7):891-892.
  • [7]梁伟,陈铖,丁国华,等.尿液足细胞与糖尿病肾病的相关关系.中国糖尿病杂志,2007,15(6):338-341.
  • [8]陈朝红,刘志红,孙骅,等.雷公藤甲素干预足细胞病变的体外观察.肾脏病与透析肾移植杂志,2007,16(2):119-126,200.
  • [9]Yeo ES,Hwang JY,Park JE,et al.Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.Yonsei Med J,2010,51 (4):519-525.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn